CClinicalTrials.gg
Active, not recruitingNCT06934460EndocrownsUpdated Apr 18, 2025

Direct Versus Indirect Endocrowns on Endodontically Treated Molars

An interventional study of Composite resin and lithium disilicate endocrown in Endodontically-Treated Teeth, Endocrown Restoration and Restoration of Posterior Teeth, sponsored by University Medical Center Groningen. Active, not recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by University Medical Center Groningen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 years 5 months after the study started (first participant enrolled Oct 2015, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this clinical trial the performance of monolithic restorations made of indirect lithium disilicate ceramic and direct resin composite materials on severe structurally compromised endodontically treated molar teeth is evaluated.

Rationale: It is presumed that indirect restoration of extensively restored endodontically treated molar teeth contributes to durability. However, there is a lack of evidence concerning the performance of both indirect ceramic and direct composite monolithic restorations. Such restorations are commonly named 'endocrowns'.

Objective: The objective of the study is to investigate which treatment modality, indirect ceramic or direct composite endocrowns, provide the best restoration of severe structurally compromised endodontically treated molar teeth in terms of clinical performance.

Study design: Randomised 5-year clinical trial with endodontically treated molar teeth restored with either indirect glass ceramic (experimental) or direct resin composite endocrowns (control).

Study population: A total of 102 severe structurally compromised endodontically treated molar teeth that need to be restored, with a maximum of two restorations per patiënt. Patients are healthy volunteers over 18 years.

Intervention: Each patiënt with a restorative indication for endodontically treated first and second molar teeth will be randomly assigned to one of two treatment groups: indirect glass ceramic endocrown or direct composite endocrown.

Read the detailed description

In this clinical trial the performance of monolithic restorations made of indirect lithium disilicate ceramic and direct resin composite materials on severe structurally compromised endodontically treated molar teeth is evaluated.

Rationale: It is presumed that indirect restoration of extensively restored endodontically treated molar teeth contributes to durability. However, there is a lack of evidence concerning the performance of both indirect ceramic and direct composite monolithic restorations. Such restorations are commonly named 'endocrowns'.

Objective: The objective of the study is to investigate which treatment modality, indirect ceramic or direct composite endocrowns, provide the best restoration of severe structurally compromised endodontically treated molar teeth in terms of clinical performance.

Study design: Randomised 5-year clinical trial with endodontically treated molar teeth restored with either indirect glass ceramic (experimental) or direct resin composite endocrowns (control).

Study population: A total of 102 severe structurally compromised endodontically treated molar teeth that need to be restored, with a maximum of two restorations per patiënt. Patients are healthy volunteers over 18 years.

Intervention: Each patiënt with a restorative indication for endodontically treated first and second molar teeth will be randomly assigned to one of two treatment groups: indirect glass ceramic endocrown or direct composite endocrown.

02

Conditions studied

  • Endodontically-Treated Teeth
  • Endocrown Restoration
  • Restoration of Posterior Teeth
  • Composite Resins

Browse trials for

Keywords

  • endocrown
  • endocrown restoration
  • composite resin
  • direct composite
  • endodontically-treated teeth
03

In context

Tooth, Nonvital

113 studies on the registry are indexed under Tooth, Nonvital; 19 are open to participants now.

This study's enrollment of 102 is above the median of 50 across 103 interventional studies indexed under Tooth, Nonvital.

Browse Tooth, Nonvital studies →

Lead sponsor

University Medical Center Groningen is the lead sponsor of 609 studies on the registry; 174 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

ASA i or II [de Jong, 1994], This ASA score is already known before participation, due to regular check-ups.

  • Asymptomatic endodontically treated and heavily restored upper and lower molar teeth with an indication for a (new) restoration.
  • Pulp chamber height of at least 2 millimeters.
  • Need of cuspal coverage;
  • Pockets around the molar 3-5 mm.
  • Moderate to low caries risk.

Exclusion criteria

Exclusion Criteria:

  • ASA III or higher.

    • Pockets around the molar >5mm.
    • Presence of an accessible furcation.
    • No biological width present (3mm).
    • Rubber dam placement not possible.
    • No antagonistic tooth.
    • History of severe parafunction.
    • High caries risk.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102 participants (actual)

Study arms

  • Active comparator
    Direct composite resin endocrown

    Direct restoration with a microhybrid composite resin

    Device: Composite resin

  • Experimental
    Lithium disilicate endocrown

    Indirect restoration with a lithium disilicate endocrown in conjunction with Immediate Dentin Sealing

    Device: lithium disilicate endocrown

Interventions

  • DeviceComposite resin

    Direct composite resin restoration after application of an adhesive system

  • Devicelithium disilicate endocrown

    Lithium disilicate endocrown in conjunction with Immediate Dentin Sealing

06

What researchers measure

Primary outcomes

  1. Restoration survival

    Failure is defined as restoration replacement or tooth extraction due to secondary decay or vertical root fracture (FDI scre 5). A FDI score of 4 or less indicates survival.

    Time frame: 5 years

Secondary outcomes

  1. Abutment tooth survival

    Failure defined as tooth extraction, regardless of cause.

    Time frame: 5 years

Other outcomes

  1. Abutment tooth success

    failure was defined as tooth extraction, the presence of endodontic pathology, or the necessity for (non-)surgical endodontic retreatment

    Time frame: 5 years

  2. Patient satisfaction

    Patient satisfaction measured on VAS-scale (0-100)

    Time frame: 1 and 5 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — Start before 2019 with the inclusion and was not mentioned in informed consent forms specifically

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06934460
Lead sponsor
University Medical Center Groningen
Responsible party
Sponsor
First posted
Apr 18, 2025
Start date
Oct 12, 2015
Primary completion
Feb 2028 (estimated)
Completion
Nov 2028 (estimated)
Last update
Apr 18, 2025

Study contacts

Marco S. Cune, Prof.dr.
study director · Department of Restorative Dentistry and Biomaterials - Center for Dentistry and Oral Hygiene - University Medical Center Groningen

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion